Deskside with Dr. Dan
FDA approves oral combination of Dacogen and Cedazuridine for patients with myelodysplastic syndromes
Dr. Dan Platt breaks down what the December 2020 FDA approval for myelodysplatic syndromes treatment of dacogen and cedazuridine combination means for patients.
Gryt Health
August 18, 2022
